Aprea Therapeutics's total assets for Q3 2025 were $14.32M, a decrease of -17.26% from the previous quarter. APRE total liabilities were $2.68M for the fiscal quarter, a -31.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.